Your session is about to expire
← Back to Search
Visual Feedback Training for Aphasia
N/A
Waitlist Available
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age range 21-75 years
Control group subjects have no history of neurological and psychiatric disorder
Must not have
Subjects with history of peripheral laryngeal disorders (e.g., paresis or vocal fold paralysis)
Subjects with moderate to severe hearing, memory, and/or cognitive impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at different types of feedback people with aphasia get when speaking to see what helps them communicate better.
Who is the study for?
This trial is for English-speaking adults aged 21-75 who have aphasia after a stroke, can perform the study tasks, and have no severe hearing or cognitive issues. Healthy controls with normal speech and no neurological disorders are also needed. Both groups must be right-handed.
What is being tested?
The study tests how visual feedback training affects speech in people with aphasia by using EEG and fMRI to track brain activity during speech tasks under altered auditory conditions. It aims to improve communication abilities and develop targeted treatments.
What are the potential side effects?
There may not be direct side effects from the interventions as this is a non-invasive study involving behavioral training and brain imaging techniques like EEG and MRI.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 21 and 75 years old.
Select...
I have never had a neurological or psychiatric disorder.
Select...
My voice, speech, language, and hearing are normal.
Select...
I have been diagnosed with a specific type of aphasia.
Select...
I am a native English speaker.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had issues with my voice box, like weakness or paralysis.
Select...
I have moderate to severe issues with hearing, memory, or thinking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Speech Production and Motor Control Ability
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Control GroupExperimental Treatment1 Intervention
Group II: Aphasia GroupExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas at DallasLead Sponsor
64 Previous Clinical Trials
106,734 Total Patients Enrolled
4 Trials studying Aphasia
185 Patients Enrolled for Aphasia
University of South CarolinaLead Sponsor
222 Previous Clinical Trials
120,303 Total Patients Enrolled
6 Trials studying Aphasia
521 Patients Enrolled for Aphasia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have speech difficulties but can still do the required tasks.You have conditions that make it unsafe for you to have an EEG or MRI scan.I have had issues with my voice box, like weakness or paralysis.I am between 21 and 75 years old.I have never had a neurological or psychiatric disorder.My voice, speech, language, and hearing are normal.I have been diagnosed with a specific type of aphasia.You use your right hand for tasks.I have had aphasia from a stroke in the left side of my brain for over 6 months.I have moderate to severe issues with hearing, memory, or thinking.I am a native English speaker.
Research Study Groups:
This trial has the following groups:- Group 1: Aphasia Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger